Pandemic influenza A virus (H1N1) 2009 poses a serious public-health challenge
worldwide. To characterize the neutralizing epitopes of this virus, we generated a panel of …

Currently, influenza vaccines are produced using embryonated chicken eggs. Recently,
recombinant influenza vaccines have been developed as a potential alternative to egg …

Background The spread of highly pathogenic avian influenza (HPAI) H5N1 virus in human
remains a global health concern. Heterosubtypic antibody response between seasonal …

ABSTRACT Between November 2013 and February 2014, China reported three human
cases of H10N8 influenza virus infection in the Jiangxi province, two of which were fatal …

Aims and Methods To facilitate antigenic characterization of the influenza A 2009 pandemic
H1N1 [A (H1N1) pdm09] hemagglutinin (HA), we generated a panel of murine monoclonal …

Please cite this paper as: Shoji et al.(2011) A plant‐based system for rapid production of
influenza vaccine antigens. Influenza and Other Respiratory Viruses 6 (3), 204–210 …

The continued evolution of influenza viruses reduces the effectiveness of vaccination and
antiviral drugs. The identification of novel and universal agents for influenza prophylaxis and …

Highly pathogenic avian H5N1 influenza viruses are endemic in poultry in Asia and pose a
pandemic threat to humans. Since the deployment of vaccines against a pandemic strain …

In 2009, a novel H1N1 swine influenza virus was isolated from infected humans in Mexico
and the United States, and rapidly spread around the world. Another virus, a highly …

Highly pathogenic avian influenza (HPAI) H5N1 virus infection is still a potential threat to
public health worldwide. While vaccines and antiviral drugs are currently under …